Next Science Limited Stock price

Equities

NXS

AU0000041329

Pharmaceuticals

Market Closed - Australian S.E. 01:10:09 2024-03-28 am EDT 5-day change 1st Jan Change
0.325 AUD -2.99% Intraday chart for Next Science Limited -12.16% -4.41%
Sales 2024 * 32.71M 50.31M Sales 2025 * 40.67M 62.56M Capitalization 63.75M 98.06M
Net income 2024 * -13M -20M Net income 2025 * -8M -12.31M EV / Sales 2024 * 1.56 x
Net cash position 2024 * 12.75M 19.61M Net cash position 2025 * 5.02M 7.72M EV / Sales 2025 * 1.44 x
P/E ratio 2024 *
-4.47 x
P/E ratio 2025 *
-10.6 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 48.62%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.99%
1 week-12.16%
Current month+3.17%
1 month+1.56%
3 months-1.52%
6 months-18.75%
Current year-4.41%
More quotes
1 week
0.32
Extreme 0.315
0.38
1 month
0.31
Extreme 0.31
0.39
Current year
0.29
Extreme 0.285
0.39
1 year
0.18
Extreme 0.18
0.78
3 years
0.18
Extreme 0.18
2.06
5 years
0.18
Extreme 0.18
4.73
10 years
0.18
Extreme 0.18
4.73
More quotes
Managers TitleAgeSince
Founder - 17-10-19
Chief Executive Officer - 23-07-09
Director of Finance/CFO - 23-05-25
Members of the board TitleAgeSince
Chief Executive Officer - 23-07-09
Director/Board Member - 23-08-22
Director/Board Member - 17-05-31
More insiders
Date Price Change Volume
24-03-28 0.325 -2.99% 96 425
24-03-27 0.335 -6.94% 64,481
24-03-26 0.36 -5.26% 65,429
24-03-25 0.38 0.00% 11,768
24-03-22 0.38 +2.70% 18,359

Delayed Quote Australian S.E., March 28, 2024 at 01:10 am EDT

More quotes
Next Science Limited is an Australia-based medical technology company. The Company's principal activities include development and commercialization of XBIO technology. The XBIO technology is a non-toxic technology used in solving the problems of bacterial biofilms-based infections in human health. Its XBIO technology is a non-toxic technology with efficacy in eradicating both biofilm based and free-floating bacteria. The Company's products include XPERIENCE, Blast X, SurgX and Bactisure. The XPERIENCE product is an antimicrobial solution used to prevent surgical site infections by rinsing away debris and microorganisms. SurgX Sterile Antimicrobial Gel is used to reduce surgical site and post-surgical infections by destroying planktonic and biofilm-based bacteria within the gel with sustained effectiveness for up to five days. The Blast X is an antimicrobial wound gel.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.2185 USD
Average target price
0.2415 USD
Spread / Average Target
+10.51%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Next Science Limited - Australian S.E.